Exelixis (EXEL) PT Raised to $51 at Stifel
Get Alerts EXEL Hot Sheet
Price: $56.19 -2.16%
Rating Summary:
14 Buy, 12 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Rating Summary:
14 Buy, 12 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Join SI Premium – FREE
Stifel analyst Stephen Willey raised the price target on Exelixis (NASDAQ: EXEL) to $51.00 (from $47.00) while maintaining a Hold rating.
You May Also Be Interested In
- FDA extends Exelixis zanzalintinib review by three months
- Jazz Pharmaceuticals (JAZZ) PT Raised to $337 at UBS on GEA Approval for Ziihera
- Adobe (ADBE) PT Raised to $255 at UBS Following Q3 Results
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share